Takeda Pharmaceutical Company Limited Share Price

Equities

4502

JP3463000004

Pharmaceuticals

Delayed Japan Exchange 06:41:50 23/05/2024 am IST 5-day change 1st Jan Change
4,126 JPY +0.59% Intraday chart for Takeda Pharmaceutical Company Limited -0.34% +1.73%

Financials

Sales 2024 4,26400Cr 2.72TCr 2,26400Cr Sales 2025 * 4,09700Cr 2.61TCr 2,17500Cr Capitalization 6,43600Cr 4.11TCr 3,41700Cr
Net income 2024 14TCr 92Cr 7.65TCr Net income 2025 * 14TCr 87Cr 7.21TCr EV / Sales 2024 1.54 x
Net Debt 2024 * 3,77100Cr 2.41TCr 2,00200Cr Net Debt 2025 * 4,20400Cr 2.68TCr 2,23200Cr EV / Sales 2025 * 2.6 x
P/E ratio 2024
45.4 x
P/E ratio 2025 *
45.5 x
Employees 49,095
Yield 2024 *
4.58%
Yield 2025 *
4.65%
Free-Float 99.12%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Takeda Pharmaceutical Company Limited

1 day+0.54%
1 week-0.34%
Current month-0.70%
1 month+0.05%
3 months-7.99%
6 months-1.88%
Current year+1.73%
More quotes
1 week
4 077.00
Extreme 4077
4 174.00
1 month
4 018.00
Extreme 4018
4 205.00
Current year
4 018.00
Extreme 4018
4 494.00
1 year
3 900.00
Extreme 3900
4 873.00
3 years
2 993.00
Extreme 2993
4 873.00
5 years
2 894.50
Extreme 2894.5
4 873.00
10 years
2 894.50
Extreme 2894.5
6 693.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 01/14/01
Chief Tech/Sci/R&D Officer 45 01/22/01
Compliance Officer 54 01/12/01
Members of the board TitleAgeSince
Director/Board Member 71 01/16/01
Director/Board Member 62 01/19/01
Director/Board Member 71 01/19/01
More insiders
Date Price Change Volume
23/24/23 4,126 +0.59% 983 300
22/24/22 4,102 -0.75% 2,557,900
21/24/21 4,133 -0.77% 2,527,700
20/24/20 4,165 +0.85% 2,987,200
17/24/17 4,130 -0.19% 3,239,600

Delayed Quote Japan Exchange, May 23, 2024 at 06:41 am IST

More quotes
Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas: - sale of drugs and consumer care products; - services. Net sales are distributed geographically as follows: Japan (17.5%), Asia (5%), the United States (49%), Europe and Canada (20.8%), Latin America (3.8%), Russia and CIS (1.8%) and other (2.1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
4,102 JPY
Average target price
4,762 JPY
Spread / Average Target
+16.10%
Consensus